NAPOLITANO, Mariasanta
 Distribuzione geografica
Continente #
NA - Nord America 15.164
EU - Europa 5.252
AS - Asia 4.822
SA - Sud America 912
Continente sconosciuto - Info sul continente non disponibili 848
AF - Africa 125
OC - Oceania 26
Totale 27.149
Nazione #
US - Stati Uniti d'America 14.851
SG - Singapore 1.789
RU - Federazione Russa 1.332
CN - Cina 1.196
IT - Italia 1.101
DE - Germania 729
BR - Brasile 728
HK - Hong Kong 465
VN - Vietnam 413
FI - Finlandia 362
PL - Polonia 336
FR - Francia 286
GB - Regno Unito 281
IE - Irlanda 192
CA - Canada 180
JP - Giappone 153
BD - Bangladesh 149
SE - Svezia 136
IN - India 129
UA - Ucraina 118
KR - Corea 116
NL - Olanda 105
TR - Turchia 79
RO - Romania 65
AR - Argentina 61
MX - Messico 49
IQ - Iraq 46
AT - Austria 39
ID - Indonesia 35
ES - Italia 34
PK - Pakistan 33
EC - Ecuador 32
ZA - Sudafrica 31
CO - Colombia 25
CR - Costa Rica 25
SA - Arabia Saudita 24
UZ - Uzbekistan 24
CH - Svizzera 23
MA - Marocco 23
VE - Venezuela 23
AU - Australia 22
BE - Belgio 21
IR - Iran 19
JM - Giamaica 18
MY - Malesia 18
CL - Cile 16
CZ - Repubblica Ceca 16
NP - Nepal 16
AE - Emirati Arabi Uniti 14
EG - Egitto 14
IL - Israele 14
GR - Grecia 13
KE - Kenya 13
PH - Filippine 11
UY - Uruguay 11
CI - Costa d'Avorio 10
DZ - Algeria 10
LT - Lituania 10
LB - Libano 9
TN - Tunisia 9
TW - Taiwan 9
AL - Albania 8
JO - Giordania 8
OM - Oman 8
PY - Paraguay 8
TH - Thailandia 8
EU - Europa 7
XK - ???statistics.table.value.countryCode.XK??? 7
BG - Bulgaria 6
DK - Danimarca 6
DO - Repubblica Dominicana 6
HN - Honduras 6
HR - Croazia 6
KZ - Kazakistan 6
TT - Trinidad e Tobago 6
GT - Guatemala 5
RS - Serbia 5
SV - El Salvador 5
AZ - Azerbaigian 4
BH - Bahrain 4
BY - Bielorussia 4
MD - Moldavia 4
NZ - Nuova Zelanda 4
PE - Perù 4
PR - Porto Rico 4
QA - Qatar 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
BO - Bolivia 3
KG - Kirghizistan 3
NG - Nigeria 3
SN - Senegal 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
CY - Cipro 2
EE - Estonia 2
LY - Libia 2
NI - Nicaragua 2
NO - Norvegia 2
Totale 26.288
Città #
Fairfield 1.599
Ashburn 1.520
Secaucus 1.362
Singapore 1.198
San Jose 839
Houston 756
Woodbridge 704
Seattle 634
Wilmington 619
Chandler 602
Cambridge 534
Hong Kong 447
Council Bluffs 415
Zgierz 302
Ann Arbor 293
Beijing 242
Santa Clara 233
Los Angeles 219
Medford 193
Dublin 191
Moscow 190
Des Moines 181
Dallas 179
Helsinki 168
Altamura 152
Tokyo 145
Lauterbourg 139
Palermo 132
Ho Chi Minh City 131
Princeton 128
New York 115
Nanjing 110
Lawrence 106
Hefei 105
Hanoi 99
Boardman 87
San Diego 87
Dearborn 80
Frankfurt am Main 78
São Paulo 68
Rome 62
Buffalo 59
London 59
Toronto 56
Chicago 53
The Dalles 53
Columbus 49
Nuremberg 48
Milan 47
Phoenix 45
Ludwigshafen am Rhein 43
Atlanta 40
Orem 37
Shenyang 37
Jacksonville 36
Lappeenranta 35
Brooklyn 33
Izmir 32
Montreal 32
Nanchang 32
Tianjin 32
Denver 31
Zhengzhou 31
Hebei 30
Shanghai 27
Seoul 26
Falls Church 24
Jiaxing 24
Mumbai 24
Redwood City 24
Springfield 24
Stockholm 24
Tulsa 24
Warsaw 24
Chennai 23
Guangzhou 23
Ningbo 22
Brussels 21
San José 21
Amsterdam 20
Haiphong 20
Belo Horizonte 19
Changsha 19
Istanbul 19
Ottawa 19
Rio de Janeiro 19
Brasília 18
Jinan 17
Tashkent 17
Baghdad 16
Hangzhou 16
Kilburn 16
Paris 16
Seongnam 16
North Bergen 15
Saint Petersburg 15
Salt Lake City 15
San Francisco 15
Bengaluru 14
City of London 14
Totale 17.104
Nome #
[Haemocoagulative modifications correlated with pregnancy] 939
Real-World Prophylaxis Outcomes with rIX-FP and rFIXFc for Males with Hemophilia B: Pooled Analysis of Medical Chart Data from Germany and Italy 753
Absolute Lymphocyte Count Is Unrelated to Overall Survival in Newly Diagnosed Elderly Patients with Multiple Myeloma Treated with Immunomodulatory Drugs. 493
Management of Pregnancy, Delivery, and Postpartum in Italian Carriers and Women With Haemophilia A and B 410
The Essential Thrombocythemia in 2020: What We Know and Where We Still Have to Dig Deep 407
Iron-dependent erythropoiesis in women with excessive menstrual blood losses and women with normal menses 376
Kinesiotaping for the Treatment of Haematomas in Haemophiliacs: a Case Control Study 333
Clinical phenotype and response to different lines of therapy in elderly with immune thrombocytopenia: A retrospective study 332
Replacement therapy for bleeding episodes in factor VII deficiency: A prospective evaluation 277
Efficacy of ruxolitinib retreatment in a patient with high-risk myelofibrosis using the international prognostic scoring system 277
Women with congenital factor VII deficiency: clinical phenotype and treatment options from two international studies 275
Optimal Duration of Low Molecular Weight Heparin for the Treatment of Cancer-Related Deep Vein Thrombosis: The Cancer-DACUS Study. 267
Peripheral circulating cells with paroxysmal nocturnal haemoglobinuria phenotype after a first episode of cerebral sinus vein thrombosis: Results from a multicentre cross-sectional study 267
Acquired haemophilia in cancer: A systematic and critical literature review 262
Buffy coat-derived platelets cryopreserved using a new method: Results from a pivotal clinical trial on thrombocytopenic patients with acute leukaemia 260
Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: a communication from the Platelet Physiology SSC 253
Hematopoietic peripheral circulating blood stem cells as an independent marker of good transfusion management in patients with β-thalassemia: results from a preliminary study 247
Role of clinical and laboratory parameters for treatment choice in patients with inherited FVII deficiency undergoing surgical procedures: evidence from the STER registry 245
Abdominal aortic thrombosis secondary to reactive thrombocytosis in a patient with iron deficiency anemia 244
A Multicenter Real-Life Study On Anticoagulant Treatment With Direct Oral Anticoagulants In Patients With Ph Negative Myeloproliferative Neoplasms 241
Acquired Hemophilia A Associated with Venous Thrombosis and Very High Inhibitor Titer: A Challenging Scenario 237
Activated prothrombin complex concentrate (FEIBA®) in acquired haemophilia A: a large multicentre Italian study - the FAIR Registry 236
Combined Point of Care Tools Are Able to Improve Treatment Adherence and Health-Related Quality of Life in Patients with Severe Hemophilia: An Observational Prospective Study 236
Autoantibody Inhibitor Eradication In Acquired Hemophilia Associated with Cancer: a Retrospective Analysis 234
Hereditary combined deficiency of the vitamin K-dependent clotting factors 233
null 231
Incidence of venous thromboembolism and use of anticoagulation in hematological malignancies: Critical review of the literature 230
Antimicrobial prophylaxis in patients with immune thrombocytopenia treated with rituximab: a retrospective multicenter analysis 230
Antimicorbial prophylaxis in patients with immune thrombocytopenia treated with rituximab:a retrospective analysis 223
Tailoring haemophilia A prophylaxis with BAY 81-8973: A case series 223
Buffy coat-derived platelets cryopreserved using a new method: Results from in vitro studies 222
Immunosenescence and lymphomagenesis 218
Factor VII Deficiency: Clinical Phenotype, Genotype and Therapy 217
Benign intracranial hypertension associated to blood coagulation derangements 217
Diagnosis and management of Evans syndrome in adults: first consensus recommendations 216
Late onset of unilateral optic disk edema secondary to treatment with imatinib mesylate 215
Clinical course of isolated distal deep vein thrombosis in patients with active cancer: A multicenter cohort study 214
Atypical presentations of thrombotic thrombocytopenic purpura in middle-aged women with recurrent cerebral macrovascular thrombosis: a case report 212
COMPARISON OF CLINICAL AND LABORATORY DATA, INCLUDING JAK-2 46/1 HAPLOTYPE, BETWEEN PATIENTS WITH IDIOPATHIC ERYTHROCYTOSIS AND POLYCYTHEMIA VERA. 209
Patient preferences in the treatment of hemophilia A: impact of storage conditions on product choice 207
Quality of Life in Patients With Cancer Under Prolonged Anticoagulation for High-Risk Deep Vein Thrombosis: a Long-Term Follow-Up 206
Correlation between FIX genotype and pharmacokinetics of Nonacog alpha according to a multicentre Italian study 205
Cardio-oncology in multiple myeloma: is it time for a specific focus? 201
Bone marrow characteristics predict outcome in a multicenter cohort of primary immune thrombocytopenia patients treated with thrombopoietin analogues 197
Management of kidney transplantation in a factor VII-deficient patient: case report. 192
JAK2 ALLELE BURDEN IN PATIENTS WITH PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE NEOPLASMS 192
Clinical history of thrombosis before diagnosis of overt myeloproliferative neoplasms in triple negative patients 191
Pharmacokinetic properties of recombinant FVIIa in inherited FVII deficiency account for a large volume of distribution at steady state and a prolonged pharmacodynamic effect 186
Emotions and Opinions of Adult Patients with Haemophilia During the COVID-19 (Coronavirus Disease 2019) Pandemic Caused by SARS-CoV-2: A Monocentric Survey 183
Cancers in Patients with von Willebrand Disease: A Survey from the Italian Association of Haemophilia Centres 182
Adverse Events in Treatment of Inherited Factor VII Deficiency: Final Analysis of the STER 180
Clostridium difficile Induced Inflammasome Activation and Coagulation Derangements 179
"Long term anticoagulant treatment management in patients with portal vein thrombosis at high bleeding risk" 178
Le emergenze emorragiche in ematologia 175
Coexistence of Von Willebrand disease and gastrointestinal stromal tumor (G.I.S.T): Case report of a rare and challenge association 175
Cryopreserved platelets: from in vitro thrombin generation potential to in vivo safety 173
Status of Recombinant Factor VIII Concentrate Treatment for Hemophilia a in Italy: Characteristics and Clinical Benefits 173
Hematopoietic Peripheral Circulating Blood Stem Cells As an Independent Marker of Good Transfusion Management in Patients with Beta-Thalassemia 172
Genetics and Pathogenetic Role of Inflammasomes in Philadelphia Negative Chronic Myeloproliferative Neoplasms: A Narrative Review 171
Addressing the impact of SARS-CoV-2 infection in persons with congenital bleeding disorders: The Italian MECCOVID-19 study 171
OC-01 - Clinical history of cancer patients with isolated distal deep vein thrombosis: a multicenter cohort study 170
Low dose of aPCC after the initial treatment in acquired haemophilia A is useful to reduce bleeding relapses: Data from the FAIR registry 169
Combined use of antifibrinolytics and activated prothrombin complex concentrate (aPCC) is not related to thromboembolic events in patients with acquired haemophilia A: data from FAIR Registry 168
Can we compare haemophilia carriers with clotting factor deficiency to male patients with mild haemophilia? 167
Effective Hemostasis During Minor Surgery in a Case of Hereditary Combined Deficiency of Vitamin K-dependent Clotting Factors 166
Invasive procedures and minor surgery in factor VII deficiency 165
Anomalie della coagulazione e angiodisplasie 165
Evidence of jak2 val617phe positive essential thrombocythemia with splanchnic thrombosis during estroprogestinic treatment 164
Lymphomas and thyroid: Bridging the gap 164
Natural and engineered carboxy-terminal variants: decreased secretion and gain-of-function result in asymptomatic coagulation factor VII deficiency. 163
Personalized prophylaxis with simoctocog-alfa(human-cl rhFVIII):A real-life experience on children and moderate haemophilia A patients 163
Bleeding Management of Uterine Conization Using a Pasteurized FVIII/VWF Concentrate in a Woman Affected by Type 2A von Willebrand Disease 162
Inhibitors to factor VII in congenital factor VII deficiency 162
Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management 162
The Prevalence of Chronic Cerebrospinal Venous Insufficiency in Meniere Disease: 24-Month Follow-up after Angioplasty 160
Coronary artery stenosis treatment in aging patients with inherited Factor VII deficiency: Where do we stand? 160
Replacement therapy in inherited factor VII deficiency: Occurrence of adverse events and relation with surgery 160
Future directions in acquired hemophilia A 159
Vitamin K-induced modification of coagulation phenotype in VKORC1 homozygous deficiency 158
Bleeding symptoms at disease presentation and prediction of ensuing bleeding in inherited FVII deficiency 158
Ultrasonography-guided central venous catheterisation in haematological patients with severe thrombocytopenia 156
Prophylaxis In Congenital Factor VII Deficiency, Indications, Efficacy and Safety: Results of the STER 156
Glucosylsphingosine (Lyso-Gb1) as a reliable biomarker in Gaucher disease: a narrative review 154
Vitamin K deficiency bleeding leading to a diagnosis of Crohn’s Disease 153
Using pharmacokinetics for tailoring prophylaxis in people with hemophilia switching between clotting factor products: A scoping review 152
Management of Venous ThromboEmbolism in patients with acute leukemia at high bleeding risk: a multicenter study 151
Clinical and biological data on the use of hydroxychloroquine against SARS-CoV-2 could support the role of the NLRP3 inflammasome in the pathogenesis of respiratory disease 149
Replacement Therapy for Minor Surgery and Invasive Procedures in Factor VII Deficiency: The STER Experience 148
Proposal and validation of a novel quantitative approach (QUEM) for the evaluation of menstrual blood losses. Preliminary implementation for the management of menorrhagia in congenital bleeding disorders. 146
Sorafenib as a feasible therapeutic option in haemophiliacs with hepatocellular carcinoma 146
Recombinant, activated factor VII for surgery in factor VII deficiency: a prospective evaluation - the surgical STER 145
The Effect of Fluctuating Temperature on the Stability of Turoctocog Alfa for Hemophilia A 142
Incidence and Management Of Venous Thrombosis In Acute Leukemia: A Multicenter Study 136
Subcortical ischaemic changes in young hypertensive patients: frequency, effect on cognitive performance and relationship with markers of endothelial and haemostatic activation 134
Fostering drug.storage,preparation and treatment modalities improves adherence to treatment with turoctocog-alfa in patients with haemophilia A:results from a short term follow-up 134
Diagnosis and treatment of chronic synovitis in patients with haemophilia: consensus statements from the Italian Association of Haemophilia Centres 134
Functional In Vitro Studies Of Buffy Coat Pooled Platelets Cryopreserved In Dimethyl-Sulphoxide With a New System 133
[Hypercoagulability during pregnancy: evidences for a thrombophilic state] 131
Oral high-dose sucrosomial iron vs intravenous iron in sideropenic anemia patients intolerant/refractory to iron sulfate: a multicentric randomized study 131
Immune thrombocytopenia in antiphospholipid syndrome: Is it primary or secondary? 130
Totale 21.426
Categoria #
all - tutte 91.090
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.090


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.239 0 0 72 73 46 80 86 110 179 209 136 248
2022/20232.091 226 409 61 191 215 303 144 192 212 19 76 43
2023/2024980 54 124 95 185 77 145 107 42 21 17 23 90
2024/20252.789 81 278 324 220 93 94 192 200 205 257 289 556
2025/202610.687 503 1.797 548 1.099 927 1.129 1.168 959 944 842 399 372
2026/20271.643 574 804 265 0 0 0 0 0 0 0 0 0
Totale 27.149